Catalyst Wire Dossier Catalyst Wire Dossier

Yervoy (Ipilimumab)

Ipilimumab · Bristol Myers Squibb
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Yervoy (Ipilimumab), covering 2015-05-13 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Real-World Outcomes of First-Line Nivolumab + Ipilimumab With Chemotherapy in Non-Small Cell Lung Cancer in Poland

See pricing